Effects of sodium-glucose cotransporter 2 inhibitors on ocular diseases in patients with diabetes melli-tus
The eye is one of the major target organs damaged by diabetes,and diabetes-related eye diseases are a group of diseases that seriously affect the quality of vision of patients and even cause blind-ness.Most of the current clinical treatments are applicable to the advanced stages of eye disease,and there is an urgent need for drugs to prevent the development of eye disease.Sodium-Glucose Transporter 2 Inhibi-tors(SGLT2i)are novel oral drugs used to reduce hyperglycaemia in diabetic patients,and have shown highly beneficial effects in diabetes-associated cardiovascular and renal diseases.Currently,the use of SGLT2i to lower blood glucose while preventing diabetes-associated eye diseases has also become a new area of research.This article mainly reviews the research progress of SGLT2i in diabetes-related eye diseases.
NETL
NSTL
万方数据
